- World rank, all time
- #30,832 of 34,923
- Rank in United States
- #6,511 of 7,310
- Research works
- 197 ▲ 19% vs 2018-21
- Citations
- 7.5k 38.3 per fractional work
- Top-10% rate
- 6.4% all institutions 10.0%
- vs its own fields
- 1.07× 1.00× is exactly expected
- Open access
- 17% world 40%
- International
- 12% world 18%
Which fields of science does Enzon Pharmaceuticals (United States) work in?
In all years, 42% of research at Enzon Pharmaceuticals (United States) is in Life Sciences, 34% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (34%), Medicine (32%), Engineering (7%). It does 2.6× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 22 fields, with their numbers
- Life Sciences8342.3%
- Health Sciences6834.4%
- Medicine6331.9%
- Veterinary21.1%
- Health Professions21.0%
- Nursing10.3%
- Dentistry00.2%
- Physical Sciences4221.1%
- Engineering147.2%
- Chemistry146.8%
- Materials Science105.2%
- Environmental Science21.0%
- Computer Science20.8%
- Chemical Engineering00.1%
- Earth and Planetary Sciences00.1%
- Social Sciences42.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 25.8×. Every wedge is a field page.
All 18 fields, with their numbers
- Veterinary25.80×0 works
- Pharmacology, Toxicology and Pharmaceutics15.75×0 works
- Chemistry9.94×2 works
- Immunology and Microbiology6.59×1 works
- Nursing2.39×0 works
- Neuroscience2.16×0 works
- Medicine2.04×4 works
- Chemical Engineering2.01×0 works
- Business, Management and Accounting1.63×0 works
- Biochemistry, Genetics and Molecular Biology1.38×1 works
- Materials Science0.74×0 works
- Health Professions0.72×0 works
- Agricultural and Biological Sciences0.55×0 works
- Environmental Science0.46×0 works
- Computer Science0.19×0 works
- Engineering0.04×0 works
- Economics, Econometrics and Finance0.03×0 works
- Social Sciences0.01×0 works
- Veterinary 25.8×
- Pharmacology, Toxicology and Pharmaceutics 15.8×
- Chemistry 9.9×
- Immunology and Microbiology 6.6×
- Nursing 2.4×
- Neuroscience 2.2×
- Medicine 2.0×
- Chemical Engineering 2.0×
- Business, Management and Accounting 1.6×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Materials Science 0.7×
- Health Professions 0.7×
- Agricultural and Biological Sciences 0.6×
- Environmental Science 0.5×
- Computer Science 0.2×
- Engineering 0.0×
- Economics, Econometrics and Finance 0.0×
- Social Sciences 0.0×
Who are the top researchers at Enzon Pharmaceuticals (United States)?
Ranked on the quality score, Lee M. Greenberger, Yixian Zhang and David R. Filpula lead among researchers whose main affiliation is Enzon Pharmaceuticals (United States).
- 1
Lee M. Greenberger
United States · #188,816 worldwide 7.7k citations · 200 works
- 2
Yixian Zhang
United States · #735,117 worldwide 4.5k citations · 155 works
- 3
David R. Filpula
United States · #736,341 worldwide 3.5k citations · 45 works
- 4
Aby Buchbinder
United States · #1,053,270 worldwide 5.9k citations · 79 works
- 5
Robert Shorr
United States · #1,370,017 worldwide 3.2k citations · 79 works
- 6
Richard B. Greenwald
United States · #1,544,823 worldwide 3.1k citations · 54 works
- 7
D Filpula
United States · #1,547,877 worldwide 1.6k citations · 19 works
- 8
Raj Bandaru
United States · #2,048,875 worldwide 752 citations · 27 works
- 9
Charles D. Conover
United States · #2,065,401 worldwide 2.1k citations · 25 works
- 10
Annapurna Pendri
United States · #2,098,673 worldwide 1.9k citations · 41 works
Which keywords describe research at Enzon Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Glycosylation, Cancer Therapy, Monoclonal Antibodies, Therapeutic Antibodies, Drug Discovery, Genomic Stability and Gene Therapy.
- Therapeutic Targets
- Mucins
- Chemotherapy-Induced Peripheral Neuropathy
- Gene Silencing
- RNA Interference
- Genomic Profiling
- Peptide Synthesis
- Protein-Protein Interactions
- Fc Receptors
- Drug Delivery
- DNA
- Anticancer Drugs
- Hemoglobin
- Targeted Therapy
- Genetic Variants
- Gene Therapy
- Drug Discovery
- Monoclonal Antibodies
- Cancer
- Glycosylation
- Chemotherapy
- Nanoparticles
- Cancer Therapy
- Therapeutic Antibodies
- Genomic Stability
- Immunotherapy
- Clinical Trials
- Biomedical Applications
- Scavenger Receptor
- Neurotoxicity
- Topoisomerases
- Antibody Engineering
- Tumor Targeting
- Foldamers
- Apoptosis
- Monoclonal Antibody
- Immune System
- siRNA Delivery
- Glycans
- Taxanes
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy14▲ 9.8×9 topics
- Glycosylation12▲ 28×3 topics
- Nanoparticles11▲ 4.1×10 topics
- Cancer10▲ 3.7×14 topics
- Cancer Therapy10▲ 7.7×7 topics
- Monoclonal Antibodies9▲ 32×3 topics
- Therapeutic Antibodies9▲ 35×2 topics
- Drug Discovery9▲ 11×5 topics
- Genomic Stability8▲ 46×2 topics
- Gene Therapy8▲ 16×5 topics
- Immunotherapy8▲ 6.3×9 topics
- Genetic Variants8▲ 19×4 topics
- Clinical Trials8▲ 6.4×7 topics
- Targeted Therapy8▲ 18×5 topics
- Biomedical Applications7▲ 3.5×9 topics
- Hemoglobin7▲ 128×1 topic
- Scavenger Receptor7▲ 128×1 topic
- Anticancer Drugs7▲ 79×2 topics
- Neurotoxicity6▲ 18×4 topics
- DNA6▲ 103×1 topic
- Topoisomerases6▲ 103×1 topic
- Drug Delivery6▲ 6.6×5 topics
- Antibody Engineering6▲ 31×1 topic
- Fc Receptors6▲ 31×1 topic
- Tumor Targeting6▲ 22×3 topics
- Protein-Protein Interactions6▲ 27×3 topics
- Foldamers5▲ 34×1 topic
- Peptide Synthesis5▲ 34×1 topic
- Apoptosis5▲ 6.8×7 topics
- Genomic Profiling5▲ 26×2 topics
- Monoclonal Antibody5▲ 36×2 topics
- RNA Interference5▲ 23×2 topics
- Immune System5▲ 7.7×3 topics
- Gene Silencing5▲ 20×1 topic
- siRNA Delivery5▲ 32×1 topic
- Chemotherapy-Induced Peripheral Neuropathy4▲ 45×1 topic
- Glycans4▲ 27×1 topic
- Mucins4▲ 27×1 topic
- Taxanes4▲ 45×1 topic
- Therapeutic Targets4▲ 8.8×6 topics
Which research topics does Enzon Pharmaceuticals (United States) publish most on?
By volume in 2022-now: Analytical Methods in Pharmaceuticals, Supply Chain Resilience and Risk Management, Analytical Chemistry and Chromatography and Animal testing and alternatives.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Analytical Methods in Pharmaceuticals Analytical Chemistry 1 works
- 2 Supply Chain Resilience and Risk Management Strategy and Management 0 works
- 3 Analytical Chemistry and Chromatography Spectroscopy 0 works
- 4 Animal testing and alternatives Small Animals 0 works
- 5 Medical Device Sterilization and Disinfection Microbiology 0 works
- 6 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
- 7 Pain Mechanisms and Treatments Physiology 0 works
- 8 Diagnosis and Treatment of Venous Diseases Surgery 0 works
- 9 Dermatologic Treatments and Research Dermatology 0 works
- 10 Drug-Induced Hepatotoxicity and Protection Pharmacology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Enzon Pharmaceuticals (United States)'s research output changed?
Output in 2022-2025 was 19% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Enzon Pharmaceuticals (United States) as a percentage of every work published that year, 0.000049% in 2024.
Fractional works of Enzon Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Piscataway
- Environmental and Occupational Health Sciences Institute
- Institute of Electrical and Electronics Engineers
- American Standard (United States)
- Diamond Materials (United States)
- Gorgias Press (United States)
- Structured Materials Industries (United States)
- African Studies Association
- Solidia Technologies (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Enzon Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
